Comera Life Sciences Holdings- Warrants (19/05/2027) Operating Income

The latest operating income for CMRAW is $-9.1M as of September 2023. That compares with $-11M in the prior-year period — up 16.7% year over year. Investors often review this figure alongside Comera Life Sciences Holdings- Warrants (19/05/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CMRAW's operating income moved from $-11M to $-9.1M — a 16.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Comera Life Sciences Holdings- Warrants (19/05/2027)'s operating scale or balance-sheet position.

A operating income figure of $-9.1M for CMRAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CMRAW's operating income ($-9.1M), review year-over-year change from $-11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.